Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CRIXIVAN DIN 02229188

Status: Cancelled Pre Market
Holder: MERCK CANADA INC
Molecule: INDINAVIR (INDINAVIR SULFATE)

Health Canada record

Active ingredient(s)INDINAVIR (INDINAVIR SULFATE) 300 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AE02 INDINAVIR
Original market date
Current status date01-Nov-2016
SourceHealth Canada DPD

Establishment licence of the holder

Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing INDINAVIR (INDINAVIR SULFATE)

DINProductCompanyFormStrengthStatus
02229161CRIXIVANMERCK CANADA INCCapsuleINDINAVIR (INDINAVIR SULFATE) 200 MGCancelled Post Market
02229196CRIXIVANMERCK CANADA INCCapsuleINDINAVIR (INDINAVIR SULFATE) 400 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
70892005-06-08New Drug Submission (NDS)MANUFACTURER NAME CHANGE
44671996-09-13New Drug Submission (NDS)
Request a quote for CRIXIVAN

How to read a Canadian DIN record